Applied Radiation and Isotopes 2011-12-01

Boron neutron capture therapy for clear cell sarcoma (CCS): biodistribution study of p-borono-L-phenylalanine in CCS-bearing animal models.

T Andoh, T Fujimoto, T Sudo, I Fujita, M Imabori, H Moritake, T Sugimoto, Y Sakuma, T Takeuchi, S Kawabata, M Kirihata, T Akisue, K Yayama, M Kurosaka, S Miyatake, Y Fukumori, H Ichikawa

Index: Appl. Radiat. Isot. 69(12) , 1721-4, (2011)

Full Text: HTML

Abstract

Clear cell sarcoma (CCS) is a rare melanocytic malignant tumor with a poor prognosis. Our previous study demonstrated that in vitro cultured CCS cells have the ability to highly uptake l-BPA and thus boron neutron capture therapy could be a new option for CCS treatment. This paper proved that a remarkably high accumulation of (10)B (45-74 ppm) in tumor was obtained even in a CCS-bearing animal with a well-controlled biodistribution followed by intravenous administration of L-BPA-fructose complex (500 mg BPA/kg).Copyright © 2011 Elsevier Ltd. All rights reserved.

Related Compounds

  • 4-Borono-L-phenyl...

Related Articles:

Pharmacokinetic analysis and uptake of 18F-FBPA-Fr after ultrasound-induced blood-brain barrier disruption for potential enhancement of boron delivery for neutron capture therapy.

2014-04-01

[J. Nucl. Med. 55(4) , 616-21, (2014)]

Low dose of gamma irradiation enhanced boronophenylalanine uptake in head and neck carcinoma cells for boron neutron capture therapy.

2011-12-01

[Appl. Radiat. Isot. 69(12) , 1728-31, (2011)]

Boron neutron capture therapy induces apoptosis of glioma cells through Bcl-2/Bax.

2010-01-01

[BMC Cancer 10 , 661, (2010)]

Studies for the application of boron neutron capture therapy to the treatment of differentiated thyroid cancer.

2011-12-01

[Appl. Radiat. Isot. 69(12) , 1752-5, (2011)]

EORTC trial 11001: distribution of two 10B-compounds in patients with squamous cell carcinoma of head and neck, a translational research/phase 1 trial.

2009-08-01

[J. Cell. Mol. Med. 13(8B) , 1653-65, (2009)]

More Articles...